first glp 1 approved Weight-loss GLP-1 pill for time by FDA, Novo Nordisk says PRESS The first GLP-1 pill
Description
Relamorelin in gastroparesis and diabetic gastroparesis: a meta-analysis on its efficacy and safety

Sci Transl Med 5: 209ra151

GLP-1 receptor agonists like semaglutide produce 15 to 20% body weight reduction in clinical trials
What began as a therapeutic advance in diabetes has evolved into a broader transformation of how metabolic diseases are treated and understood